GISELLE D MANN
Speech Language Pathology at 43 St, Gainesville, FL
License number
Florida 2555
Issued Date
Jan 31, 2001
Effective Date
Feb 11, 2003
Expiration Date
Jan 31, 2003
Category
Health Care
Type
Provisional Speech-Language Pathologist
Address
Address
1813 NW 43 St, Gainesville, FL 32605
Phone
(352) 392-7655
Personal information
See more information about GISELLE D MANN at radaris.comName
Address
Phone
8959 SW 44Th Ln, Gainesville, FL 32608
8959 44Th St, Gainesville, FL 32608
3515 30Th St, Gainesville, FL 32605
Professional information
Program Director, Phd In Public Health At University Of Florida
Position:
Program Director, PhD in Public Health at University of Florida, Associate Professor at University of Florida
Location:
Gainesville, Florida Area
Industry:
Hospital & Health Care
Work:
University of Florida
since 2010
-
Program Director, PhD in Public Health
University of Florida
since 2007
-
Associate Professor
UF
2000 - 2013
-
Associate Professor
University of Florida
2005 - 2007
-
Research Associate Scientist
Cutin University of Technology
1994 - 2000
-
Lecturer
Royal Perth Hospital
1994 - 2000
-
Stroke Unit Research Fellow
Curtin University
1983 - 2000
-
Speech Pathology
Royal Perth Hospital
1988 - 1994
-
Speech Pathologist
Education:
Curtin University of Technology 1983 - 1998
MPH, PhD, Public Health, Speech Pathology Santa Maria College
MPH, PhD, Public Health, Speech Pathology Santa Maria College
Interests:
Public Health research , research methodology, biostatistics, program development & evaluation
Honor & Awards:
American Cancer Society Scholar
Methods To Prevent Or Ameliorate Medication-, Procedure-Or Stress-Induced Cognitive And Speech Dysfunction And Methods To Optimize Cognitive And Speech Functioning
US Patent:
2005009, May 5, 2005
Filed:
Nov 3, 2003
Appl. No.:
10/700156
Inventors:
Nathan Shapira - Gainesville FL, US
Giselle Mann - Gainesville FL, US
April Annis - Gainesville FL, US
Toby Goldsmith - Gainesville FL, US
Giselle Mann - Gainesville FL, US
April Annis - Gainesville FL, US
Toby Goldsmith - Gainesville FL, US
Assignee:
University of Florida - Gainesville FL
International Classification:
A61K031/445, A61K031/137
US Classification:
514317000, 514649000
Abstract:
Many medications, herbal remedies and procedures have side affects that contribute to cognitive dysfunction. Because of these side effects patients may choose to discontinue medication or treatment (such as ECT) which has a detrimental effect on treatment. Currently, there are no medications approved for helping to alleviate these symptoms. The invention describes a novel treatment for individuals who experience various side effects of cognitive dysfunction. The invention additionally describes how these medications may enhance cognitive function in individuals with normal cognitive functioning who might benefit from this type of enhancement. The subject invention further provides materials and methods for the treatment, prevention, or ameliorate medication-induced cognitive dysfunction comprising the administration of medications or compositions comprising at least one selective norepinephrine reuptake inhibitors (SNR1) and/or buproprion.